by Paul McIntosh | Oct 12, 2020 | Press Releases, Uncategorized
NovaBiotics’ founder and Chief Executive Officer, Dr Deborah O’Neil FRSE, was amongst those recognised in the Queen’s 2020 Birthday Honours list. Deborah was made an Officer of the Most Excellent order of the British Empire (OBE) for services to biotechnology,...
by Paul McIntosh | Jul 7, 2020 | Press Releases
NovaBiotics are delighted to announce that our latest publication is accessible from today. Teamwork focused on solutions to antimicrobial resistance with our collaborators – Marcelo Der Torossian Torres, University of Pennsylvania Cesar de la Fuente, University...
by Paul McIntosh | Apr 13, 2020 | Press Releases
NovaBiotics, the clinical stage antimicrobials drug discovery company, announces the rapid repurposing of Nylexa for the ‘hidden killer’ underlying COVID-19: secondary bacterial lung infections. Nylexa ‘supercharges’ antibiotics, boosting their efficacy against...
by Paul McIntosh | Mar 31, 2020 | Press Releases
NovaBiotics announces its latest peer-reviewed publication describing data confirming the stand-out properties of Novexatin® (NP213), NovaBiotics’ brush-on treatment for fungal nail infection (onychomycosis). The paper, “NP213 (Novexatin®): A unique therapy candidate...
Recent Comments